As of 2025-04-30, the Relative Valuation of Dyne Therapeutics Inc (DYN) is (31.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.72 USD, the upside of Dyne Therapeutics Inc based on Relative Valuation is -368.1%.
The range of the Relative Valuation is (27.93) - (36.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 14.1x | 10.9x |
| Forward P/E multiples | 10.0x - 13.2x | 11.6x |
| Fair Price | (27.93) - (36.87) | (31.43) |
| Upside | -338.3% - -414.6% | -368.1% |
| Date | P/E |
| 2025-04-24 | -3.98 |
| 2025-04-23 | -3.86 |
| 2025-04-22 | -3.55 |
| 2025-04-21 | -3.34 |
| 2025-04-17 | -2.92 |
| 2025-04-16 | -2.80 |
| 2025-04-15 | -2.81 |
| 2025-04-14 | -2.67 |
| 2025-04-11 | -2.52 |
| 2025-04-10 | -2.50 |
| 2025-04-09 | -2.70 |
| 2025-04-08 | -2.44 |
| 2025-04-07 | -2.68 |
| 2025-04-04 | -2.96 |
| 2025-04-03 | -3.37 |
| 2025-04-02 | -3.55 |
| 2025-04-01 | -3.30 |
| 2025-03-31 | -3.74 |
| 2025-03-28 | -4.10 |
| 2025-03-27 | -4.22 |
| 2025-03-26 | -4.03 |
| 2025-03-25 | -4.08 |
| 2025-03-24 | -4.44 |
| 2025-03-21 | -4.32 |
| 2025-03-20 | -4.39 |
| 2025-03-19 | -4.44 |
| 2025-03-18 | -4.50 |
| 2025-03-17 | -4.41 |
| 2025-03-14 | -4.31 |
| 2025-03-13 | -4.25 |
| 2025-03-12 | -4.42 |
| 2025-03-11 | -4.31 |
| 2025-03-10 | -4.12 |
| 2025-03-07 | -4.44 |
| 2025-03-06 | -4.38 |
| 2025-03-05 | -4.36 |
| 2025-03-04 | -4.26 |
| 2025-03-03 | -4.41 |
| 2025-02-28 | -4.87 |
| 2025-02-27 | -4.71 |
| 2025-02-26 | -4.94 |
| 2025-02-25 | -4.85 |
| 2025-02-24 | -4.86 |
| 2025-02-21 | -5.02 |
| 2025-02-20 | -5.01 |
| 2025-02-19 | -4.95 |
| 2025-02-18 | -4.93 |
| 2025-02-14 | -4.98 |
| 2025-02-13 | -5.03 |
| 2025-02-12 | -4.98 |